Turning Point Brands Inc (TPB) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company's strong financial growth, positive analyst sentiment, and significant market potential in the oral nicotine pouch category outweigh the current technical weakness and market volatility.
The stock is currently oversold with an RSI of 10.022, indicating a potential rebound. However, the MACD is negatively expanding (-5.855), and the price is below key support levels. The short-term trend is bearish, but long-term prospects remain strong.

Q4 2025 revenue increased by 144.60% YoY, net income rose 239.26% YoY, and EPS grew by 223.08% YoY.
Modern oral nicotine product sales surged 266% YoY, with projections for this category to account for half of total revenue by the end of
Analyst Aaron Grey raised the price target to $135, citing strong growth potential.
Apis Capital Advisors increased its stake in TPB, signaling institutional confidence.
Gross margin dropped by 34.32% YoY in Q4 2025, indicating potential cost pressures.
The stock fell 20% recently, reflecting market uncertainty.
The MACD and technical indicators suggest short-term bearish momentum.
In Q4 2025, TPB achieved a 144.60% YoY revenue increase to $121.01 million, a 239.26% YoY net income growth to $8.21 million, and a 223.08% YoY EPS rise to $0.42. However, gross margin dropped to 55.91%, down 34.32% YoY.
Alliance Global analyst Aaron Grey raised the price target to $135 from $110 and maintained a Buy rating. The analyst expects healthy sales growth in 2026 and sees TPB as a leader in the modern oral pouch category.